24R, 25‐Dihydroxyvitamin D₃ ameliorates the high‐turnover bone diseases without suppressing parathyroid function in chronic renal failure in rats

This publication has 24 references indexed in Scilit:

• Long-term effect of oral calcitriol pulse therapy on bone in hemodialysis patients
  Bone, 1993
• Assessment of combined 24,25(oh)2d3 and 1α(oh)d3 therapy for bone disease in dialysis patients
  Bone, 1992
• Effect of 24,25- Dihydroxycholecalciferol on Intestinal Absorption of Calcium and Phosphate and on Parathyroid Hormone Secretion in Chronic Renal Failure
  Nephron, 1992
• Regulation of parathyroid hormone synthesis in chronic renal failure in rats
  Kidney International, 1991
• Oral Administration of 24,25(OH)2D3 Suppresses the Serum Parathyroid Hormone Levels of Dialysis Patients
  Nephron, 1991
• Renal bone disease 1990: An unmet challenge for the nephrologist
  Kidney International, 1990
• Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure
  New England Journal of Medicine, 1989
• Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
  Journal of Bone and Mineral Research, 1987
• Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.
  Journal of Clinical Investigation, 1984
• Effect of 24,25(OH)2D3 on PTH levels and bone histology in dogs with chronic uremia
  Kidney International, 1984